RAPT Therapeutics, Inc. Operating Cash Flow
RAPT Therapeutics, Inc. reported Operating Cash Flow of -$76.14 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-06
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$12.46M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$11.27M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$52.41M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$10.44M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$83.30M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$97.05M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$70.77M.
- RAPT Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$61.03M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$12.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$23.73M derived: sum of 2 quarters · filed 2025-11-06 | -$76.14M 10-Q · filed 2025-11-06 | -$86.58M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$11.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$63.69M 10-Q · filed 2025-08-07 | -$74.12M derived: sum of 3 quarters · filed 2025-08-07 | -$91.74M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$52.41M 10-Q · filed 2025-05-08 | -$62.85M derived: sum of 2 quarters · filed 2025-05-08 | -$80.47M derived: sum of 3 quarters · filed 2025-11-06 | -$108.63M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$28.06M derived: sum of 2 quarters · filed 2025-11-06 | -$56.21M derived: sum of 3 quarters · filed 2025-11-06 | -$83.30M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$17.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$45.78M derived: sum of 2 quarters · filed 2025-11-06 | -$72.86M 10-Q · filed 2025-11-06 | -$100.61M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$28.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$55.24M 10-Q · filed 2025-08-07 | -$82.99M derived: sum of 3 quarters · filed 2025-08-07 | -$104.88M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$27.08M 10-Q · filed 2025-05-08 | -$54.84M derived: sum of 2 quarters · filed 2025-05-08 | -$76.72M derived: sum of 3 quarters · filed 2025-05-08 | -$105.53M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$27.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$49.64M derived: sum of 2 quarters · filed 2025-03-06 | -$78.45M derived: sum of 3 quarters · filed 2025-03-06 | -$97.05M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$21.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$50.69M derived: sum of 2 quarters · filed 2024-11-12 | -$69.29M 10-Q · filed 2024-11-12 | -$92.14M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$28.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$47.41M 10-Q · filed 2024-08-08 | -$70.26M derived: sum of 3 quarters · filed 2024-08-08 | -$87.41M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$18.60M 10-Q · filed 2024-05-09 | -$41.45M derived: sum of 2 quarters · filed 2024-05-09 | -$58.60M derived: sum of 3 quarters · filed 2024-05-09 | -$73.80M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$22.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$40.00M derived: sum of 2 quarters · filed 2024-03-07 | -$55.19M derived: sum of 3 quarters · filed 2024-03-07 | -$70.77M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$17.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$32.34M derived: sum of 2 quarters · filed 2023-11-13 | -$47.92M 10-Q · filed 2023-11-13 | -$68.60M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$30.77M 10-Q · filed 2023-08-11 | -$51.45M derived: sum of 3 quarters · filed 2023-08-11 | -$63.97M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$15.58M 10-Q · filed 2023-05-11 | -$36.26M derived: sum of 2 quarters · filed 2023-05-11 | -$48.78M derived: sum of 3 quarters · filed 2023-05-11 | -$62.69M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$20.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$33.20M derived: sum of 2 quarters · filed 2023-03-14 | -$47.12M derived: sum of 3 quarters · filed 2023-03-14 | -$61.03M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$12.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$26.43M derived: sum of 2 quarters · filed 2022-11-10 | -$40.34M 10-Q · filed 2022-11-10 | -$55.71M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$13.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$27.83M 10-Q · filed 2022-08-11 | -$43.19M derived: sum of 3 quarters · filed 2022-08-11 | -$53.15M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$13.91M 10-Q · filed 2022-05-11 | -$29.28M derived: sum of 2 quarters · filed 2022-05-11 | -$39.23M derived: sum of 3 quarters · filed 2022-05-11 | -$45.66M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$15.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$25.32M derived: sum of 2 quarters · filed 2022-03-10 | -$31.75M derived: sum of 3 quarters · filed 2022-03-10 | -$40.49M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$9.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$16.38M derived: sum of 2 quarters · filed 2021-11-10 | -$25.13M 10-Q · filed 2021-11-10 | -$30.81M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$6.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$15.17M 10-Q · filed 2021-08-11 | -$20.86M derived: sum of 3 quarters · filed 2021-08-11 | -$33.00M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$8.74M 10-Q · filed 2021-05-11 | -$14.43M derived: sum of 2 quarters · filed 2021-05-11 | -$26.57M derived: sum of 3 quarters · filed 2021-05-11 | -$35.59M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$17.83M derived: sum of 2 quarters · filed 2021-03-11 | -$26.84M derived: sum of 3 quarters · filed 2021-03-11 | -$35.47M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$12.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$21.15M derived: sum of 2 quarters · filed 2020-11-16 | -$29.79M 10-Q · filed 2020-11-16 | -$39.00M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$9.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$17.65M 10-Q · filed 2020-08-13 | -$26.86M derived: sum of 3 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$8.63M 10-Q · filed 2020-05-14 | -$17.84M derived: sum of 2 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$32.95M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | -$23.74M 10-Q · filed 2019-12-11 |